Insights

Post-Bankruptcy Opportunities Following Endo's emergence from Chapter 11 bankruptcy and its reorganization as Endo, Inc., there is a significant opportunity to tailor sales strategies towards rebuilding brand confidence and expanding market presence within its core therapeutic areas, emphasizing innovation and reliability.

Innovative Product Launches Endo's recent development of advanced products such as the Spatial Computing Injection Simulator and branded therapies like Xiaflex indicates a focus on cutting-edge medical technologies and treatments, opening doors for partnerships, supply agreements, and technology licensing with healthcare providers and institutions.

Expanding Generics Portfolio The launch of Tiopronin delayed-release tablets suggests an active push in the generic pharmaceuticals market, providing opportunities to connect with generic distributors, hospitals, and clinics looking for affordable, quality medication options in this therapeutic segment.

Strategic Asset Divestments Sale of assets such as the Paladin Pharma unit to Knight Therapeutics signals a strategic focus on core competencies and may present opportunities for targeted sales efforts in specialty pharma channels, as well as prospects for collaborations with Canadian healthcare firms.

Focus on Digital Engagement Endo's adoption of advanced tech stacks like Salesforce Marketing Cloud and Acquia Cloud sites demonstrates a commitment to digital marketing and engagement, paving the way for opportunities in digital advertising services, CRM integrations, and targeted outreach campaigns to healthcare professionals.

Endo Tech Stack

Endo uses 8 technology products and services including CCPA, Webpack, MasterControl, and more. Explore Endo's tech stack below.

  • CCPA
    Certificates
  • Webpack
    Development
  • MasterControl
    Document Management Systems
  • IBM Maximo
    Facilities Management
  • Modernizr
    Javascript Libraries
  • Salesforce Marketing Cloud
    Marketing Performance Measurement
  • Akamai Web Application Protector
    Security
  • Acquia Cloud Site Factory
    Web Hosting

Media & News

Endo's Email Address Formats

Endo uses at least 1 format(s):
Endo Email FormatsExamplePercentage
Last.First@endo.comDoe.John@endo.com
72%
First.Last@endo.comJohn.Doe@endo.com
22%
First@endo.comJohn@endo.com
4%
LastFirst@endo.comDoeJohn@endo.com
2%

Frequently Asked Questions

Where is Endo's headquarters located?

Minus sign iconPlus sign icon
Endo's main headquarters is located at Malvern, Arkansas United States. The company has employees across 6 continents, including North AmericaAsiaEurope.

What is Endo's phone number?

Minus sign iconPlus sign icon
You can contact Endo's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Endo's stock symbol?

Minus sign iconPlus sign icon
Endo is a publicly traded company; the company's stock symbol is ECYT.

What is Endo's official website and social media links?

Minus sign iconPlus sign icon
Endo's official website is endo.com and has social profiles on LinkedIn.

What is Endo's SIC code NAICS code?

Minus sign iconPlus sign icon
Endo's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Endo have currently?

Minus sign iconPlus sign icon
As of June 2026, Endo has approximately 1.5K employees across 6 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: A. B.Ceo: S. M.Ceo: D. H.. Explore Endo's employee directory with LeadIQ.

What industry does Endo belong to?

Minus sign iconPlus sign icon
Endo operates in the Pharmaceutical Manufacturing industry.

What technology does Endo use?

Minus sign iconPlus sign icon
Endo's tech stack includes CCPAWebpackMasterControlIBM MaximoModernizrSalesforce Marketing CloudAkamai Web Application ProtectorAcquia Cloud Site Factory.

What is Endo's email format?

Minus sign iconPlus sign icon
Endo's email format typically follows the pattern of Last.First@endo.com. Find more Endo email formats with LeadIQ.

When was Endo founded?

Minus sign iconPlus sign icon
Endo was founded in 1997.
Endo logo

Endo

Pharmaceutical ManufacturingArkansas, United States1001-5000 Employees

Endo is a pharmaceutical manufacturer based in Malvern, Arkansas, employing a sizeable workforce. In 2025, the company merged with Mallinckrodt Pharmaceuticals to better serve customers and improve outcomes for the patients it supports. As a result, two independent entities were formed: Keenova Therapeutics, focused on branded therapeutics, and Par Health, focused on generics and sterile injectables.

These standalone entities reflect an organizational split within the pharmaceutical manufacturing space, with Keenova handling branded therapies and Par Health handling generics and sterile injectables. Keenova and Par Health maintain a presence on LinkedIn and operate dedicated websites at keenova.com and parhealth.com. In March 2025, Endo announced a new initiative related to spatial computing for injection procedures, marking a notable development in its activities.

Section iconCompany Overview

Headquarters
Malvern, Arkansas United States
Phone number
Website
endo.com
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
Stock Symbol
ECYT
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1997
Employees
1001-5000

Section iconFunding & Financials

  • $1B$10B

    Endo's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $1B$10B

    Endo's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.